NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Henry Meds

Henry Meds

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://henrymeds.com/

Last Round

Seed

Oct 14, 2022

Total Funding Raised

$2.2M

Company Overview

Henry Meds is a healthcare company that operates a telehealth platform offering subscription-based services for weight management, hormone replacement, and other endocrine conditions.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce, Pharma Supply Chain, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

telehealth weight losscompounded GLP-1compounded semaglutidecompounded tirzepatidedirect-to-consumer telehealthOzempic alternativecompounded Ozempicweight loss medicationsubscription medicationcompounding pharmacycash-pay healthcaretestosterone replacement therapyTRThormone replacement therapyHRTerectile dysfunction treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Henry Meds Comparables

Compare Henry Meds with similar companies based on industry and business-model similarity.

Henry Meds comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ivim Health
92%
Mochi Health
91%
OrderlyMeds
90%

Henry Meds Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 14, 2022

Key People

Founding team and executive leadership

Ian Gruber

Chief Operating Officer

Executive Team

Henry Meds Investors

Notable investors and investment history

Henry Meds investors
InvestorRounds
SecwaysSeed
Vye VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2024

    Grew 28% QoQ, from 318 to 406 employees.

  • Aug 31, 2024

    Grew 37% QoQ, from 283 to 387 employees.

Henry Meds Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Henry Meds Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Henry Meds's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range162
Year Founded2022
Last FundingOct 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.